Sponsor pipeline

UroGen Pharma Ltd. clinical trial pipeline

4 active trials 2 recruiting 3 Phase 3 1 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 3

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT06774131	A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract…	Upper Urinary Tract Urothelial Carcinoma	Recruiting	2026-06-16
NCT05243550	A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk…	Bladder Cancer	Active, Not Recruiting	2026-05-11
NCT06331299	A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk…	Bladder Cancer	Active, Not Recruiting	2026-01-15
Not specified
NCT05874921	uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC)…	Urothelial Carcinoma	Recruiting	2025-02-28

Get alerts when UroGen Pharma Ltd.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.